Inventor · disambiguated record
Fukumi Morishige
Also filed as: MORISHIGE FUKUMI
5 granted patents·6 pending applications·53 citations·filing 1985–2012
79Inventor score
Top patents by PatentIndex Score
11 records- 0180US4851390ANutritional methods utilizing compositions containing RNA, CA+2, Mg+2 and/or ascorbateNISSAN CHEMICAL IND LTD·Filed 1986·Granted Jul 25, 1989·32 cites·20 claims
- 0271US6552074B2Arginine/ascorbic acid mixed powder as an oral supplementMORISHIGE FUKUMI·Filed 2001·Granted Apr 22, 2003·7 cites·9 claims
- 0365US7214709B2Arginine/ascorbic acid mixed powder as an oral supplementKIMOTO EIJI·Filed 2002·Granted May 8, 2007·3 cites·3 claims
- 0456US4839172AComposition of accelerating recovery of function of hematopoietic organsNISSAN CHEMICAL IND LTD·Filed 1985·Granted Jun 13, 1989·9 cites·15 claims
- 0556US2005234122A1Prevention of and countermeasures against viral infectionCHOKO CO LTD·Filed 2004·Application pending·0 cites
- 0655US2009209640A1Prevention of and countermeasures against viral infectionFUMIE MORISHIGE·Filed 2009·Application pending·0 cites
- 0750US2005256186A1Prevention of and countermeasures against mitochondrial diseaseFUMIE MORISHIGE·Filed 2004·Application pending·0 cites
- 0846US2012322863A1Prevention of and countermeasures against mitochondrial diseaseMORISHIGE FUKUMI·Filed 2012·Application pending·0 cites
- 0943US2010113578A1Prevention of and countermeasures against mitochondrial diseaseFUMIE MORISHIGE·Filed 2010·Application pending·0 cites
- 1042US2011020463A1Therapeutic agent for fibromyalgia syndrome and therapeutic agent for pain caused by muscle spasmMORISHIGE FUKUMI·Filed 2008·Application pending·0 cites
- 1120US6454695B1Therapeutic instrument for treating or relieving psoriasis, atopic dermatitis, articular rheumatism and/or cancer or preventing the progress of these diseases and method of utilization thereofMORISHIGE FUMIE·Filed 1999·Granted Sep 24, 2002·2 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Fukumi Morishige files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →